Toxic effects of hexaammine cobalt(III) chloride on liver and kidney in mice: Implication of oxidative stress

Drug and Chemical Toxicology

Volumn 32, Issue 3, 2009, Pages 293-299

  Naura, Amarjit S ^a,b   Sharma, Rajeshwar ^a  

^a PANJAB UNIVERSITY   (India)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hexaammine cobalt(III) chloride; Kidney toxicity; Liver; Oxidative stress

Indexed keywords

AMINE; COBALT CHLORIDE; CREATININE; HEXAAMMINE COBALT CHLORIDE; UNCLASSIFIED DRUG; UREA; ANTINEOPLASTIC AGENT; COBALT; COBALT AMMONIUM COMPLEX; CREATINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG ACCUMULATION; DRUG DOSE COMPARISON; KIDNEY; KIDNEY FUNCTION TEST; LIPID PEROXIDATION; LIVER; LIVER FUNCTION TEST; LUNG; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; SPLEEN; TISSUE DISTRIBUTION; TOXICITY TESTING; UREA BLOOD LEVEL; ANIMAL; ATOMIC ABSORPTION SPECTROMETRY; BAGG ALBINO MOUSE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY;

MUS;

ACUTE TOXICITY TESTS; ANIMALS; ANTICARCINOGENIC AGENTS; COBALT; CREATINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; KIDNEY; KIDNEY FUNCTION TESTS; LIPID PEROXIDATION; LIVER; LIVER FUNCTION TESTS; LUNG; MALE; MICE; MICE, INBRED BALB C; OXIDATIVE STRESS; SPECTROPHOTOMETRY, ATOMIC; TISSUE DISTRIBUTION; UREA;

EID: 70349916146     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540902882234     Document Type: Article

References (34)

1. Ajith, T.A., Jose, N., Janardhanan, K.K. (2002). Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus. J Exp Clin Cancer Res 21:213-217.
2. Bradner, W.T., Schurig, J.E., Huftalen, J.B., Doyle, G.J. (1980). Evaluation of antitumor drug side effects in small animals. Cancer Chemother Pharmacol 4:95-101.
3. Buege, J.A., Aust, S.D. (1978). Microsomal lipid peroxidation. Meth Enzymol 52:302-310.
4. Delehanty, J.B., Bongard, J.E., Thach, D.C., Knight, D.A., Hickey, T.E., Chang, E.L. (2008). Antiviral properties of cobalt(III)- complexes. Bioorg Med Chem 16:830-837.
5. Ebina, Y., Okada, S., Hamazaki, S., Ogino, F., Li, J.L., Midorikawa, O. (1986). Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst 76:107-113.
6. Ellman, G.L. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-77.
7. Ercal, N., Gurer-Orhan, H., Aykin-Burns, N. (2001). Toxic metals and oxidative stress part I: mechanisms involved in metalinduced oxidative damage. Curr Top Med Chem 1:529-539.
8. Goldstein, R.S., Mayor, G.H. (1983). Minireview. The nephrotoxicity of cisplatin. Life Sci 32:685-690.
9. Gunter, T.E., Pfeiffer, D.R. (1990). Mechanisms by which mitochondria transport calcium. Am J Physiol 258(5 Pt 1): C755-C786.
10. Hultman, P., Eneström, S., von Schenck, H. (1985). Renal handling of inorganic mercury in mice. The early excretion phase following a single intravenous injection of mercuric chloride studied by the Silver Amplification method. Virchows Arch B Cell Pathol Incl Mol Pathol 49:209-224.
11. Karovica, O., Tonazzinia, I., Rebolaa, N., Edströmb, E., Lövdahla, C., Fredholma, B.B., Daréa, E. (2007). Toxic effects of cobalt in primary cultures of mouse astrocytes: Similarities with hypoxia and role of HIF-1a. Biochem Pharmacol 73:694-708.
12. Kollmannsberger, C., Kuzcyk, M., Mayer, F., Hartmann, J.T., Kanz, L., Bokemeyer, C. (1999). Late toxicity following curative treatment of testicular cancer. Semin Surg Oncol 17:275-281.
13. Kono, Y. (1978). Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186:189-195.
14. Köpf-Maier, P., Funke-Kaiser, P. (1986). Organ toxicity of metallocene dichlorides. The effect of (C5H5)2TiCl2 and (C5H5)2VCl2 on renal structure. Toxicology 38:81-90.
15. Kovala-Demertzi, D., Hadjipavlou-Litina, D., Staninska, M., Primikiri, A., Kotoglou, C., Demertzis, M.A. (2008). Antioxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II), and zinc(II). J Enzyme Inhib Med Chem Aug 7:1. [Epub ahead of print].
16. Loehrer, P.J., Einhorn, L.H. (1984). Drugs five years later. Cisplatin Ann Intern Med 100:704-713.
17. Lowry, O.H., Rosenbrough, N.J., Farr, A.L., Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
18. Luck, H. (1971). Catalase. In: Bergmeyer, H.U. (Eds.), Methods of Enzymatic Analysis. New York: Academic Press.
19. Maliakel, D.M., Kagiya, T.V., Nair, C.K. (2008). Prevention of cisplatin- induced nephrotoxicity by glucosides of ascorbic acid and alpha-tocopherol. Exp Toxicol Pathol 60:521-527.
20. Naura, A.S., Sharma, R. (2009). Studies on mode of action of hexaammine Co(III) chloride against diethylnitrosamine induced hepatocarcinogenesis in mice. J Biochem Mol Toxicol (in press).
21. Naura, A.S., Kalla, N.R., Sharma, R.P., Sharma, R. (2007). Anticarcinogenic effects of hexaammine cobalt(III) chloride in mice initiated with diethylnitrosamine. Biol Trace Elem Res 119:147-165. (Pubitemid 47585004)
22. Onisky, S., Levitin, I., Bubnovskaya, L., Sigan, A., Ganusevich, I., Michailenko, V., et al. (2000). Biological activities of inorganic cobalt (III) complexes with tetradentate Schiff's bases. Int J Med Biol Environ 28:83-87.
23. Osinsky, S., Levitin, I., Bubnovskaya, L., Sigan A., Ganusevich I., Kovelskaya A., Valkovskaya N., Campanella, L., Wardman, P. (2004). Selectivity of effects of redox-active cobalt (III) complexes on tumor tissue. Exp Oncol 26:140-144.
24. Ott, I., Gust, R. (2005). Stability, protein binding, and thiol interaction studies on [2-acetoxy-(2-propynyl)benzoate]hexacarbonyldicobalt. Biometals 18:171-177.
25. Ott, I., Kircher, B., Gust, R. (2004). Investigations on the effects of cobalt-alkyne complexes on leukemia and lymphoma cells: cytotoxicity and cellular uptake. J Inorg Biochem 98:485-489.
26. Richmond, R.C., Simic, M., Powers, E.L. (1975). Radiation sensitivity of Bacillus megaterium spores in the presence of Co(III) complexes, Radiat Res 63:1140-1148.
27. Roth, T., Eckert, C., Fiebig, H.H., Jung, M. (2002) Comparative action of cobalt carbonyl complexes on cancer cells using human tumor xenografts. Anticancer Res 22:2281-2284.
28. Schmidt, K., Jung, M., Keilitz, R., Schnurr, B., Gust, R. (2000). Acetylenehexacarbonyldicobalt complexes, a novel class of antitumor drugs. Inorgan Chim Acta 306:6-16.
29. Schroeder, H.A., Nason, A.P. (1974). Interactions of trace metals in rat tissues. Cadmium and nickel with zinc, chromium, copper, and manganese. J Nutr 104:167-178.
30. Singh, A., Kalla, N.R., Sharma, R.P., Sharma, R. (2007). Effects of hexaammine cobalt(III) chloride on oxidative stress-related parameters and drug metabolizing enzymes in mice. J Environ Pathol Toxicol Oncol 26:1-8.
31. Teicher, B.A., Jacobs, J.L., Cathecart, K.N.S., Abrams, M.J., Volano, J.F., Picker, D.H. (1987). Some complexes of cobalt(III) and iron(III) are radiosensitizers of hypoxic EMT cell. Radiat Res 109:36-46.
32. Tsubamoto, Y., Eto, K., Noda, M., Daniel, S., Suga, S., Yamashita, S., et al. (2001). Hexamminecobalt(III) chloride inhibits glucose- induced insulin secretion at the exocytotic process. J Biol Chem 276:2979-2985.
33. Valko, M., Morris, H., Cronin, M.T. (2005). Metals, toxicity, and oxidative stress. Curr Med Chem 12:1161-1208.
34. Yao, X., Panichpisal, K., Kurtzman, N., Nugent, K. (2007). Cisplatin nephrotoxicity: a review. Am J Med Sci 334:115-124.